Black women (BW) experience age-adjusted breast cancer mortality rates that are 40% higher than White women. Although, screening rates for breast cancer are similar between White and Black women, differences in mammography utilization exist among women with lower socioeconomic status (SES). Moreover, perceived everyday discrimination (PED) has been shown to have an inverse relationship on health screening behavior among BW.
View Article and Find Full Text PDFThe present study investigates the impact of Hispanic women's marital status on the occurrence of intimate partner violence (IPV) and reproductive coercion (RC), resulting in unintended pregnancy (UIP). This is a significant public health concern as prior research has shown Hispanic women are disproportionately affected by UIP more than non-Hispanic White women. Data were drawn from the 2018 to 2020 Pregnancy Risk Assessment Monitoring System dataset of Hispanic women ( = 3,725) who have just given birth within the last 9 months and responded to all relevant survey items.
View Article and Find Full Text PDFThe current global water crisis has prompted research into technologies that can reuse different water resources to mitigate water scarcity. The use of treated greywater can be proposed to provide additional water resources. By reusing this water in different applications, this water crisis can be mitigated at the local scale.
View Article and Find Full Text PDFSystemic lupus erythematosus is a remitting relapsing autoimmune disease characterized by autoantibody production and multi-organ involvement. T cell epigenetic dysregulation plays an important role in the pathogenesis of lupus. We have previously demonstrated upregulation of the key epigenetic regulator EZH2 in CD4 T cells isolated from lupus patients.
View Article and Find Full Text PDFBackground: Baricitinib, commonly used for autoimmune diseases, is typically administered orally, which can lead to systemic adverse effects. A topical formulation could potentially offer localized therapeutic effects while minimizing these side effects.
Objectives: This study focuses on developing a lipid-based topical formulation of baricitinib (BCT-OS) for treating psoriasis.